Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a leading global pharmaceutical company headquartered in China with a focus on research, development, manufacturing, and commercialization of innovative and high-quality healthcare products. Innovation is the core development strategy. we have focused our R&D efforts in antineoplastic drugs, surgery medications, and medicines that treat autoimmune diseases, metabolic diseases and cardiovascular diseases. Hengrui Pharma has been on the Pharma Exec’s annual listing of the top 50 global pharmaceutical companies for the fifth consecutive year. Hengrui Pharma ranked 24th among the top 1,000 global pharma companies announced by the Torreya in 2021. Hengrui Pharma ranked 13th in the “Top 25 global pharma companies by pipeline size ” selected by Informa Pharma Intelligence in 2023.